Echo IQ to Revise and Resubmit CPT Code Application

EchoIQ Limited ( (AU:EIQ) ) has shared an update.

Echo IQ announced that its application for a Category III CPT code for EchoSolv AS in the US was unsuccessful at the recent CPT Editorial Panel Meeting. The company is working with the American Medical Association and other stakeholders to revise and resubmit its application, aiming for the next panel cycle. Despite this setback, Echo IQ remains confident in its reimbursement strategy and continues to advance its technology deployment and partnerships in the US, with no interruption to the current use of EchoSolv AS.

The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.38 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.

More about EchoIQ Limited

Echo IQ is an AI and Medical Technology company based in Sydney, Australia, specializing in AI-driven technology and proprietary software to enhance decision-making in Cardiology.

Average Trading Volume: 2,904,267

Technical Sentiment Signal: Hold

Current Market Cap: A$154.8M

Learn more about EIQ stock on TipRanks’ Stock Analysis page.